| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.617 | 0.002 | 0.617 | 5 Hydroxytryptamine 3 antagonist | 0.315 0.004 DBMET01834 0.307 0.004 DBMET01835 0.257 0.004 DBMET01836 | ||
| 0.5 | 0.002 | 0.5 | 5 Hydroxytryptamine 3B antagonist | 0.196 0.003 DBMET01834 0.191 0.003 DBMET01835 0.118 0.004 DBMET01836 | ||
| 0.439 | 0.009 | 0.439 | 5 Hydroxytryptamine antagonist | 0.242 0.026 DBMET01834 0.226 0.029 DBMET01835 0.279 0.021 DBMET01836 | ||
| 0.393 | 0.01 | 0.393 | Cholinergic | 0.345 0.014 DBMET01834 0.326 0.015 DBMET01835 0.304 0.018 DBMET01836 | ||
| 0.361 | 0.006 | 0.361 | 5 Hydroxytryptamine 2C antagonist | 0.23 0.014 DBMET01834 0.226 0.014 DBMET01835 0.189 0.019 DBMET01836 | ||
| 0.35 | 0.011 | 0.35 | 5 Hydroxytryptamine 2B antagonist | 0.223 0.022 DBMET01834 0.23 0.022 DBMET01835 0.152 0.04 DBMET01836 | ||
| 0.341 | 0.013 | 0.341 | 5 Hydroxytryptamine 2 antagonist | 0.208 0.029 DBMET01834 0.204 0.029 DBMET01835 0.198 0.031 DBMET01836 | ||
| 0.331 | 0.01 | 0.331 | Acetylcholinesterase inhibitor | 0.31 0.012 DBMET01834 0.292 0.014 DBMET01835 0.27 0.017 DBMET01836 | ||
| 0.379 | 0.071 | 0.427 | GABA C receptor rho-3 antagonist | 0.367 0.077 DBMET01834 0.427 0.05 DBMET01835 0.276 0.133 DBMET01836 | DBMET01835 | |
| 0.257 | 0.023 | 0.257 | Acetylcholine M1 receptor antagonist | 0.251 0.025 DBMET01834 0.246 0.026 DBMET01835 0.256 0.024 DBMET01836 | ||
| 0.272 | 0.059 | 0.272 | Potassium channel (Voltage-sensitive) blocker | 0.152 0.135 DBMET01834 0.154 0.134 DBMET01835 | ||
| 0.229 | 0.017 | 0.229 | 5 Hydroxytryptamine 2A antagonist | 0.126 0.035 DBMET01834 0.125 0.035 DBMET01835 0.124 0.036 DBMET01836 | ||
| 0.266 | 0.056 | 0.297 | Cyclic AMP phosphodiesterase inhibitor | 0.297 0.043 DBMET01834 0.259 0.059 DBMET01835 0.174 0.118 DBMET01836 | DBMET01834 | |
| 0.211 | 0.02 | 0.211 | Butyrylcholinesterase inhibitor | 0.184 0.024 DBMET01834 0.164 0.029 DBMET01835 0.149 0.034 DBMET01836 | ||
| 0.205 | 0.017 | 0.205 | GABA receptor agonist | 0.153 0.034 DBMET01834 0.145 0.039 DBMET01835 0.143 0.04 DBMET01836 | ||
| 0.176 | 0.018 | 0.176 | Histamine H1 receptor antagonist | 0.094 0.045 DBMET01834 0.09 0.048 DBMET01835 0.096 0.043 DBMET01836 | ||
| 0.16 | 0.008 | 0.16 | GABA A receptor antagonist | 0.111 0.014 DBMET01834 0.1 0.016 DBMET01835 0.071 0.025 DBMET01836 | ||
| 0.221 | 0.079 | 0.221 | HERG channel blocker | |||
| 0.151 | 0.009 | 0.151 | GABA receptor antagonist | 0.103 0.015 DBMET01834 0.093 0.017 DBMET01835 0.066 0.028 DBMET01836 | ||
| 0.172 | 0.033 | 0.179 | Acetylcholine muscarinic antagonist | 0.161 0.038 DBMET01834 0.161 0.038 DBMET01835 0.179 0.031 DBMET01836 | DBMET01836 | |
| 0.163 | 0.038 | 0.191 | DNA intercalator | 0.161 0.038 DBMET01834 0.156 0.04 DBMET01835 0.191 0.028 DBMET01836 | DBMET01836 | |
| 0.151 | 0.027 | 0.151 | Alpha 2 adrenoreceptor antagonist | 0.119 0.037 DBMET01834 0.124 0.035 DBMET01835 0.087 0.058 DBMET01836 | ||
| 0.128 | 0.008 | 0.128 | 5 Hydroxytryptamine 3A antagonist | 0.066 0.048 DBMET01834 0.066 0.047 DBMET01835 | ||
| 0.124 | 0.004 | 0.124 | 5 Hydroxytryptamine 4 antagonist | 0.093 0.008 DBMET01834 0.093 0.008 DBMET01835 0.085 0.011 DBMET01836 | ||
| 0.192 | 0.085 | 0.217 | Psychostimulant | 0.168 0.102 DBMET01834 0.183 0.09 DBMET01835 0.217 0.071 DBMET01836 | DBMET01836 | |
| 0.156 | 0.049 | 0.156 | Cholinergic antagonist | 0.143 0.057 DBMET01834 0.145 0.055 DBMET01835 0.155 0.049 DBMET01836 | ||
| 0.115 | 0.018 | 0.115 | Benzodiazepine agonist | |||
| 0.148 | 0.051 | 0.148 | Acetylcholine antagonist | 0.136 0.058 DBMET01834 0.138 0.057 DBMET01835 0.148 0.051 DBMET01836 | ||
| 0.107 | 0.011 | 0.107 | Protein kinase C beta inhibitor | 0.106 0.011 DBMET01834 0.1 0.013 DBMET01835 0.073 0.041 DBMET01836 | ||
| 0.116 | 0.026 | 0.116 | GABA A receptor agonist | 0.082 0.059 DBMET01834 0.08 0.064 DBMET01835 0.083 0.058 DBMET01836 | ||
| 0.146 | 0.06 | 0.146 | Pregnane X receptor agonist | 0.14 0.074 DBMET01834 0.128 0.106 DBMET01835 | ||
| 0.181 | 0.106 | 0.181 | Potassium channel blocker | |||
| 0.127 | 0.053 | 0.127 | Alpha 2b adrenoreceptor antagonist | 0.099 0.076 DBMET01834 0.105 0.071 DBMET01835 | ||
| 0.088 | 0.018 | 0.119 | NMDA 2B receptor antagonist | 0.114 0.013 DBMET01834 0.119 0.012 DBMET01835 0.097 0.016 DBMET01836 | DBMET01835 | |
| 0.08 | 0.017 | 0.08 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.088 | 0.029 | 0.088 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.09 | 0.032 | 0.09 | Alpha adrenoreceptor agonist | 0.076 0.041 DBMET01834 0.086 0.034 DBMET01835 0.07 0.046 DBMET01836 | ||
| 0.183 | 0.127 | 0.188 | MAP-kinase-activated kinase 5 inhibitor | 0.188 0.12 DBMET01834 0.187 0.121 DBMET01835 | DBMET01834 | |
| 0.086 | 0.032 | 0.086 | Cannabinoid receptor agonist | |||
| 0.242 | 0.19 | 0.242 | Analgesic | 0.228 0.205 DBMET01834 | ||
| 0.085 | 0.032 | 0.085 | Neuronal nicotinic receptor antagonist | 0.067 0.047 DBMET01834 0.072 0.043 DBMET01835 | ||
| 0.112 | 0.06 | 0.181 | Topoisomerase I inhibitor | 0.164 0.036 DBMET01834 0.155 0.039 DBMET01835 0.181 0.031 DBMET01836 | DBMET01836 | |
| 0.1 | 0.051 | 0.101 | Phosphodiesterase 6D inhibitor | 0.101 0.049 DBMET01834 0.1 0.051 DBMET01835 0.089 0.08 DBMET01836 | DBMET01834 | |
| 0.072 | 0.023 | 0.072 | Melanin-concentrating hormone receptor 1 antagonist | |||
| 0.087 | 0.043 | 0.087 | Transforming growth factor beta 3 antagonist | 0.077 0.074 DBMET01835 | ||
| 0.083 | 0.043 | 0.083 | Acetylcholine M4 receptor antagonist | |||
| 0.087 | 0.048 | 0.087 | Acetylcholine nicotinic antagonist | 0.071 0.067 DBMET01834 0.073 0.064 DBMET01835 | ||
| 0.041 | 0.007 | 0.041 | CYP24 inhibitor | 0.04 0.007 DBMET01834 0.037 0.008 DBMET01835 0.033 0.009 DBMET01836 | ||
| 0.094 | 0.061 | 0.094 | Alpha 2d adrenoreceptor antagonist | |||
| 0.086 | 0.057 | 0.086 | Hematopoietic | 0.085 0.06 DBMET01834 0.085 0.059 DBMET01835 | ||
| 0.154 | 0.125 | 0.154 | Anticonvulsant | |||
| 0.173 | 0.149 | 0.181 | 5 Hydroxytryptamine release stimulant | 0.181 0.14 DBMET01834 | DBMET01834 | |
| 0.063 | 0.039 | 0.083 | Aromatase inhibitor | 0.083 0.026 DBMET01834 0.078 0.029 DBMET01835 0.075 0.031 DBMET01836 | DBMET01834 | |
| 0.037 | 0.015 | 0.037 | Protein kinase C beta II inhibitor | 0.037 0.014 DBMET01834 0.036 0.016 DBMET01835 0.03 0.028 DBMET01836 | ||
| 0.129 | 0.108 | 0.129 | GABA C receptor rho-2 antagonist | 0.129 0.108 DBMET01835 | ||
| 0.059 | 0.038 | 0.059 | Alpha 1 adrenoreceptor agonist | 0.054 0.045 DBMET01835 | ||
| 0.048 | 0.027 | 0.058 | Dopamine D5 antagonist | 0.058 0.02 DBMET01834 0.051 0.024 DBMET01835 0.042 0.03 DBMET01836 | DBMET01834 | |
| 0.055 | 0.035 | 0.055 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.14 | 0.121 | 0.152 | Lipocortins synthesis antagonist | 0.152 0.102 DBMET01834 0.136 0.128 DBMET01836 | DBMET01834 | |
| 0.055 | 0.036 | 0.055 | Thromboxane synthase inhibitor | 0.052 0.043 DBMET01834 0.051 0.047 DBMET01835 | ||
| 0.07 | 0.052 | 0.07 | Telomerase inhibitor | |||
| 0.085 | 0.067 | 0.085 | Phosphodiesterase I inhibitor | 0.08 0.076 DBMET01834 0.083 0.071 DBMET01836 | ||
| 0.067 | 0.049 | 0.067 | Protein kinase C alpha inhibitor | |||
| 0.135 | 0.121 | 0.283 | Amyloid beta aggregation inhibitor | 0.224 0.066 DBMET01834 0.208 0.074 DBMET01835 0.283 0.048 DBMET01836 | DBMET01836 | |
| 0.072 | 0.058 | 0.072 | Phosphodiesterase VI inhibitor | 0.069 0.065 DBMET01834 0.071 0.059 DBMET01835 | ||
| 0.194 | 0.183 | 0.198 | Vasodilator, peripheral | 0.198 0.179 DBMET01834 0.196 0.18 DBMET01836 | DBMET01834 | |
| 0.193 | 0.185 | 0.193 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.051 | 0.044 | 0.051 | Bromodomain-containing protein 4 inhibitor | |||
| 0.058 | 0.053 | 0.089 | Dopamine D1 antagonist | 0.089 0.029 DBMET01834 0.078 0.034 DBMET01835 0.071 0.039 DBMET01836 | DBMET01834 | |
| 0.028 | 0.023 | 0.028 | Glutamate (mGluR2) antagonist | |||
| 0.055 | 0.052 | 0.055 | 5 Hydroxytryptamine 2A agonist | |||
| 0.054 | 0.051 | 0.054 | Alpha 2 adrenoreceptor agonist | |||
| 0.08 | 0.078 | 0.08 | Antihistaminic | |||
| 0.031 | 0.032 | 0.032 | Protein kinase C beta I inhibitor | 0.032 0.029 DBMET01834 | DBMET01834 | |
| 0.126 | 0.13 | 0.149 | Antipruritic | 0.13 0.123 DBMET01834 0.149 0.096 DBMET01836 | DBMET01836 | |
| 0.045 | 0.052 | 0.051 | Protein kinase C eta inhibitor | 0.051 0.042 DBMET01834 0.049 0.044 DBMET01835 | DBMET01834 | |
| 0.09 | 0.097 | 0.096 | Protein kinase C gamma inhibitor | 0.096 0.084 DBMET01834 | DBMET01834 | |
| 0.053 | 0.062 | 0.088 | Opioid mu receptor antagonist | 0.088 0.036 DBMET01834 0.082 0.039 DBMET01835 | DBMET01834 | |
| 0.072 | 0.081 | 0.103 | Opioid antagonist | 0.103 0.046 DBMET01834 0.098 0.049 DBMET01835 0.081 0.068 DBMET01836 | DBMET01834 | |
| 0.028 | 0.046 | 0.033 | Tubulin agonist | 0.033 0.026 DBMET01836 | DBMET01836 | |
| 0.084 | 0.103 | 0.138 | Topoisomerase II inhibitor | 0.136 0.057 DBMET01834 0.124 0.064 DBMET01835 0.138 0.055 DBMET01836 | DBMET01836 | |
| 0.064 | 0.089 | 0.09 | Opioid kappa receptor antagonist | 0.09 0.046 DBMET01834 0.084 0.052 DBMET01835 | DBMET01834 | |
| 0.022 | 0.05 | 0.039 | Catechol O-methyltransferase inhibitor | 0.033 0.022 DBMET01834 0.033 0.022 DBMET01835 0.039 0.014 DBMET01836 | DBMET01836 | |
| 0.051 | 0.094 | 0.085 | Topoisomerase II alpha inhibitor | 0.085 0.049 DBMET01834 0.075 0.057 DBMET01835 | DBMET01834 | |
| 0.12 | 0.176 | 0.142 | Platelet aggregation inhibitor | 0.142 0.139 DBMET01835 | DBMET01835 | |
| 0.206 | 0.264 | 0.349 | Calcium channel L-type activator | 0.266 0.188 DBMET01834 0.349 0.118 DBMET01835 0.24 0.217 DBMET01836 | DBMET01835 | |
| 0.143 | 0.218 | 0.198 | DNA synthesis inhibitor | 0.175 0.161 DBMET01834 0.176 0.159 DBMET01835 0.198 0.126 DBMET01836 | DBMET01836 | |
| 0.04 | 0.114 | 0.057 | Heat shock protein 90 beta antagonist | 0.056 0.047 DBMET01834 0.057 0.045 DBMET01835 | DBMET01835 | |
| 0.111 | 0.19 | 0.135 | MAP kinase kinase 4 inhibitor | 0.135 0.1 DBMET01834 | DBMET01834 | |
| 0.176 | 0.261 | 0.262 | Antibacterial | 0.239 0.188 DBMET01834 0.227 0.199 DBMET01835 0.262 0.166 DBMET01836 | DBMET01836 | |
| 0.048 | 0.167 | 0.1 | Bronchodilator | 0.1 0.064 DBMET01836 | DBMET01836 | |
| 0.034 | 0.157 | 0.072 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.072 0.059 DBMET01836 | DBMET01836 | |
| 0.174 | 0.314 | 0.258 | Apoptosis agonist | 0.258 0.205 DBMET01834 0.257 0.207 DBMET01835 0.248 0.216 DBMET01836 | DBMET01834 | |
| 0.051 | 0.202 | 0.076 | MAP kinase kinase 7 inhibitor | 0.076 0.06 DBMET01834 | DBMET01834 | |
| 0.184 | 0.346 | 0.258 | Caspase 9 stimulant | 0.258 0.243 DBMET01835 | DBMET01835 | |
| 0.009 | 0.242 | 0.042 | Cathepsin L2 inhibitor | 0.042 0.027 DBMET01836 | DBMET01836 | |
| 0.106 | 0.371 | 0.214 | Sodium/bile acid cotransporter inhibitor | 0.214 0.17 DBMET01834 | DBMET01834 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |